JP2021519596A5 - - Google Patents

Info

Publication number
JP2021519596A5
JP2021519596A5 JP2020554442A JP2020554442A JP2021519596A5 JP 2021519596 A5 JP2021519596 A5 JP 2021519596A5 JP 2020554442 A JP2020554442 A JP 2020554442A JP 2020554442 A JP2020554442 A JP 2020554442A JP 2021519596 A5 JP2021519596 A5 JP 2021519596A5
Authority
JP
Japan
Prior art keywords
ferritin
ferritin protein
cysteine
polypeptide
protein
Prior art date
Application number
JP2020554442A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519596A (ja
JPWO2019195316A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025422 external-priority patent/WO2019195316A1/en
Publication of JP2021519596A publication Critical patent/JP2021519596A/ja
Publication of JPWO2019195316A5 publication Critical patent/JPWO2019195316A5/ja
Publication of JP2021519596A5 publication Critical patent/JP2021519596A5/ja
Priority to JP2024018289A priority Critical patent/JP2024054277A/ja
Pending legal-status Critical Current

Links

JP2020554442A 2018-04-03 2019-04-02 フェリチンタンパク質 Pending JP2021519596A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024018289A JP2024054277A (ja) 2018-04-03 2024-02-09 フェリチンタンパク質

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862652217P 2018-04-03 2018-04-03
US201862652204P 2018-04-03 2018-04-03
US201862652199P 2018-04-03 2018-04-03
US201862652201P 2018-04-03 2018-04-03
US201862652210P 2018-04-03 2018-04-03
US62/652,199 2018-04-03
US62/652,217 2018-04-03
US62/652,204 2018-04-03
US62/652,210 2018-04-03
US62/652,201 2018-04-03
PCT/US2019/025422 WO2019195316A1 (en) 2018-04-03 2019-04-02 Ferritin proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024018289A Division JP2024054277A (ja) 2018-04-03 2024-02-09 フェリチンタンパク質

Publications (3)

Publication Number Publication Date
JP2021519596A JP2021519596A (ja) 2021-08-12
JPWO2019195316A5 JPWO2019195316A5 (https=) 2022-04-07
JP2021519596A5 true JP2021519596A5 (https=) 2022-04-07

Family

ID=66397427

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554442A Pending JP2021519596A (ja) 2018-04-03 2019-04-02 フェリチンタンパク質
JP2024018289A Pending JP2024054277A (ja) 2018-04-03 2024-02-09 フェリチンタンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024018289A Pending JP2024054277A (ja) 2018-04-03 2024-02-09 フェリチンタンパク質

Country Status (5)

Country Link
US (2) US11904009B2 (https=)
EP (1) EP3773698A1 (https=)
JP (2) JP2021519596A (https=)
CN (1) CN112512564A (https=)
WO (1) WO2019195316A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
CN112512564A (zh) 2018-04-03 2021-03-16 赛诺菲 铁蛋白蛋白
BR112020019938A2 (pt) 2018-04-03 2021-01-26 Sanofi polipeptídeos antigênicos de vírus sincicial respiratório
CN114957407A (zh) 2019-04-02 2022-08-30 赛诺菲 抗原性多聚呼吸道合胞病毒多肽
EP4132478A1 (en) 2020-04-09 2023-02-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
BR112022021208A8 (pt) * 2020-04-22 2023-02-23 Medicago Inc Supraestrutura compreendendo hemaglutinina de influenza modificada com interação reduzida com ácido siálico
IL302397A (en) 2020-10-28 2023-06-01 Sanofi Pasteur Liposomes containing a TLR4 agonist, their preparation and uses
CN112094355B (zh) * 2020-11-23 2021-05-11 南京佰抗生物科技有限公司 一种用于临床诊断的复合质控品及其制备方法
US20240197868A1 (en) 2021-04-02 2024-06-20 Universite De Versailles-Saint-Quentin-En-Yvelines Immunogenic composition containing an antigen and an adjuvant comprising al-mofs
US20240207392A1 (en) * 2021-04-13 2024-06-27 Modernatx, Inc. Epstein-barr virus mrna vaccines
CN116396398B (zh) * 2023-01-16 2024-07-16 四川大学 一种实现铁蛋白纳米颗粒可控自组装的方法以及基于该方法搭建的纳米颗粒抗原展示平台
US20250281605A1 (en) * 2024-03-08 2025-09-11 Sanofi Antigenic Epstein Barr Virus Polypeptides
CN118221832B (zh) * 2024-04-10 2025-02-18 合肥工业大学 一种精准缀合多肽的抗冻铁蛋白及其制备方法
CN120078740B (zh) * 2025-03-05 2025-11-14 北京理工大学 一种基于铁蛋白纳米平台的毛细胞保护剂及其治疗听力损失的应用

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585250A (en) 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
EP1504037B1 (en) 2002-05-10 2009-12-30 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
AU2008339984A1 (en) 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccine
WO2009126816A1 (en) 2008-04-09 2009-10-15 Ventria Bioscience Production of ospa for lyme disease control
EP3705133B1 (en) 2010-05-14 2024-06-26 Baxalta Incorporated Ospa chimeras and use thereof in vaccines
WO2012006180A1 (en) 2010-06-29 2012-01-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv immunogens
EP2694109A4 (en) 2011-04-07 2015-02-18 Neotope Biosciences Ltd COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEIN AGGREGATION DISEASES WITH IC3B DEPOSITION
EP2515112B1 (en) 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
JP5795184B2 (ja) * 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
US9580475B2 (en) 2011-06-20 2017-02-28 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for H1N1 influenza
WO2013039792A1 (en) 2011-09-12 2013-03-21 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunogens based on an hiv-1 gp120 v1v2 epitope
IN2014CN02114A (https=) 2011-09-20 2015-05-29 Sinai School Medicine
CA2849822C (en) * 2011-09-23 2021-05-11 Gary J. Nabel, M.D. Novel influenza hemagglutinin protein-based vaccines
RU2639551C2 (ru) 2012-03-30 2017-12-21 Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вирусов гриппа h5n1 и h1n1
AU2013295647B2 (en) 2012-07-26 2018-02-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Multimeric fusion protein vaccine and immunotherapeutic
FI2970398T3 (fi) 2013-03-13 2024-08-06 Us Health Rsv f -prefuusioproteiineja ja niiden käyttö
US10744199B2 (en) * 2013-10-11 2020-08-18 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Epstein-Barr virus vaccines
CZ2014320A3 (cs) 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
CA2950085A1 (en) 2014-05-27 2015-12-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
WO2016138160A1 (en) * 2015-02-24 2016-09-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
KR20180088458A (ko) * 2015-12-04 2018-08-03 다나-파버 캔서 인스티튜트 인크. 암의 치료를 위한 mica/b 알파 3 도메인의 백신접종
US11174292B2 (en) 2016-03-29 2021-11-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Substitutions-modified prefusion RSV F proteins and their use
EP3463444B1 (en) * 2016-06-07 2024-10-16 Deutsches Krebsforschungszentrum Improvement of hpv l2 peptide immunogenicity
FI3471760T3 (fi) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita
EP3474893A1 (en) * 2016-06-27 2019-05-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
UA129243C2 (uk) 2017-04-19 2025-02-26 Інстітьют Фо Рісьорч Ін Біомедцін Антитіло, що зв'язується зі спорозоїтами p. falciparum
EP3713601A4 (en) 2017-11-21 2022-03-09 Modernatx, Inc. VACCINES AGAINST EPSTEIN-BARR VIRUS
BR112020019938A2 (pt) 2018-04-03 2021-01-26 Sanofi polipeptídeos antigênicos de vírus sincicial respiratório
CN112512564A (zh) * 2018-04-03 2021-03-16 赛诺菲 铁蛋白蛋白
CA3095174A1 (en) 2018-04-03 2019-10-10 Sanofi Antigenic ospa polypeptides
CN112512565A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性流感-铁蛋白多肽
CN112512566A (zh) * 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽

Similar Documents

Publication Publication Date Title
JP2021519596A5 (https=)
JP2021519598A5 (https=)
JPWO2019195316A5 (https=)
JP2021519597A5 (https=)
JP2023162283A5 (https=)
JP2016199557A5 (https=)
JP2023018073A5 (https=)
IL288541B (en) Vaccine against rsv
DK2590675T3 (en) ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS
JP2021519600A5 (https=)
JP2018532382A5 (https=)
JP2008530975A5 (https=)
JP2013518052A5 (https=)
JP2004537308A5 (https=)
RU2019113989A (ru) Лекарственное средство
JP7843244B2 (ja) クリックomv
JP2018501258A5 (https=)
HRP20140886T1 (hr) MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU
JPWO2019195291A5 (https=)
US20180244724A1 (en) Polypeptide compound and preparation method and use thereof
JP6541158B2 (ja) 粘膜ワクチン用アジュバント
MX2025002402A (es) Particulas tipo virus modificadas de cmv
JPWO2019197567A5 (https=)
JPWO2019195314A5 (https=)
WO2018062217A1 (ja) エボラウイルスワクチン